OPANA ER
Peakoxymorphone hydrochloride
NDAORALTABLET, EXTENDED RELEASEPriority Review
Approved
Dec 2011
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
2
Clinical Trials (2)
Bioavailability of Oxymorphone Hydrochloride 40 mg Extended Release Tablets Under Fasted Conditions
Started Nov 2007
50 enrolled
Pain
Bioavailability of Oxymorphone Hydrochloride 40 mg Extended Release Tablets Under Fed Conditions
Started Nov 2007
32 enrolled
Pain
Loss of Exclusivity
LOE Date
Nov 22, 2029
45 months away
Patent Expiry
Nov 22, 2029